A judge on Monday removed a South Dakota effort to cap drug prices in the state from a statewide ballot, STAT reports.
The court reportedly found the proponents of the measure improperly garnered some of the initiative’s signatures that qualified it for a statewide vote.
A legal complaint filed by South Dakotans Against the Deceptive Rx Ballot Issue ultimately stopped the initiative dead in its tracks. The group’s chairwoman, Joni Johnson, serves as executive director of South Dakota Biotech, an affiliate of Biotechnology Innovation Organization.
“IM26 was about deception from the beginning,” the group said in a statement. “Proponents of this deceptive proposal took a bad idea rejected by voters in California and Ohio, funded it with contributions from an out-of-state health care organization and violated the law in attempting to qualify it for the ballot.”
To read the full report on STAT, click here.